These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24276527)

  • 21. Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
    Hughes E; Tshiaba P; Wagner S; Judkins T; Rosenthal E; Roa B; Gallagher S; Meek S; Dalton K; Hedegard W; Adami CA; Grear DF; Domchek SM; Garber J; Lancaster JM; Weitzel JN; Kurian AW; Lanchbury JS; Gutin A; Robson ME
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.
    McTiernan A; Kuniyuki A; Yasui Y; Bowen D; Burke W; Culver JB; Anderson R; Durfy S
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):333-8. PubMed ID: 11319173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic.
    Ahsan MD; Webster EM; Wolfe IA; McGonigle R; Brewer JT; Chandler IR; Weiss JM; Enriquez A; Cantillo E; Holcomb K; Chapman-Davis E; Blank SV; Sharaf RN; Frey MK
    Gynecol Oncol; 2024 Apr; 183():47-52. PubMed ID: 38503141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.
    Valero MG; Zabor EC; Park A; Gilbert E; Newman A; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Mar; 27(3):736-740. PubMed ID: 31559544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study.
    Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1187-1194. PubMed ID: 31015199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening women with a family history of breast cancer--results from the British Familial Breast Cancer Group.
    Macmillan RD
    Eur J Surg Oncol; 2000 Mar; 26(2):149-52. PubMed ID: 10744933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Models for risk assessment and prediction in breast cancer].
    Hu Z; Li X; Feng MH; Chu JJ; Xie W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Oct; 30(10):1073-7. PubMed ID: 20193393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
    Louro J; Román M; Posso M; Vázquez I; Saladié F; Rodriguez-Arana A; Quintana MJ; Domingo L; Baré M; Marcos-Gragera R; Vernet-Tomas M; Sala M; Castells X;
    PLoS One; 2021; 16(3):e0248930. PubMed ID: 33755692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography?
    Gui GP; Hogben RK; Walsh G; A'Hern R; Eeles R
    Eur J Cancer; 2001 Sep; 37(13):1668-73. PubMed ID: 11527694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family history and risk of breast cancer: an analysis accounting for family structure.
    Brewer HR; Jones ME; Schoemaker MJ; Ashworth A; Swerdlow AJ
    Breast Cancer Res Treat; 2017 Aug; 165(1):193-200. PubMed ID: 28578505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting breast cancer risk in a racially diverse, community-based sample of potentially high-risk women.
    Meadows RJ; Figueroa W; Shane-Carson KP; Padamsee TJ
    Cancer Med; 2022 Nov; 11(21):4043-4052. PubMed ID: 35388639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
    Weisstock CR; Rajapakshe R; Bitgood C; McAvoy S; Gordon PB; Coldman AJ; Parker BA; Wilson C
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1084-92. PubMed ID: 23963801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing a family risk assessment clinic for breast cancer.
    Mulsow J; Lee J; Dempsey C; Rothwell J; Geraghty JG
    Breast J; 2009; 15 Suppl 1():S33-8. PubMed ID: 19775328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in Breast Cancer Risk Model Estimates Among Women in Their 40s Seen in Primary Care.
    Schonberg MA; Karamourtopoulos M; Pinheiro A; Davis RB; Sternberg SB; Mehta TS; Gilliam EA; Tung NM
    J Womens Health (Larchmt); 2022 Apr; 31(4):495-502. PubMed ID: 35073183
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.
    Evans DG; Harkness E; Lalloo F; Howell A
    J Med Genet; 2014 Sep; 51(9):573-80. PubMed ID: 25053764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of changing breast cancer incidence rates on the calibration of the Gail model.
    Schonfeld SJ; Pee D; Greenlee RT; Hartge P; Lacey JV; Park Y; Schatzkin A; Visvanathan K; Pfeiffer RM
    J Clin Oncol; 2010 May; 28(14):2411-7. PubMed ID: 20368565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.